Skip to main content
. 2019 Jan 4;3(1):16–23. doi: 10.5811/cpcem.2018.11.39667

Table 1.

Diagnostic criteria via Diagnostic and Statistical Manual of Mental Disorders (DSM-5),5 Levenson,4 and Caroff and Mann.6

Source Presentation features Diagnostic criteria
Diagnostic and Statistical Manual of Mental Disorders (DSM-5)5
  • Exposure to dopamine antagonist within 72 hours prior to symptom development

  • Hyperthermia (>100.4°F or >38°C on at least two occasions)

  • Generalized rigidity

  • Creatine kinase elevation (at least four times upper limit of normal)

  • Changes in mental status

  • Autonomic instability (tachycardia, diaphoresis, blood pressure elevation or fluctuation, urinary incontinence, pallor)

Presence of these cardinal features are suggestive of diagnosis
Major:
  • Fever

  • Rigidity

  • Elevated creatine phosphokinase concentration

Minor:
  • Tachycardia

  • Abnormal arterial pressure

  • Tachypnea

  • Altered consciousness

  • Diaphoresis

  • Leukocytosis

Presence of all three major, or two major and four minor features
Caroff, Mann 1936 Major:
  • Treatment of neuroleptics within seven days of onset (2–4 weeks for depot)

  • Hyperthermia

  • Muscle rigidity

  • Exclusion of other drug-induced, systemic, or neuropsychiatric illnesses

Minor:
  • Change in mental status

  • Tachycardia, hypertension or hypotension, tachypnea or silorrhea

  • Tremors

  • Incontinence

  • Creatine phosphokinase elevation or myoglobinuria, leukocytosis, metabolic acidosis

Presence of all four major items and five minor features